HeyJaredArijit Gupta
- Indexed articles, last 90 days
- 7
- Latest publication
- Aug 2, 2026
- Outlet visibility, for @theweek
- Top 500K sites
- Earliest in this view
- Jul 9, 2026
Latest articles
You can improve brain health even in your 90s, study finds (opens the original)
Read excerpt
Recent study challenges the belief that cognitive decline is inevitable, showing that brain health can improve at any age Researchers tracked nearly 4,000 adults and found sustained gains in thinking, emotional stability, and social connectedness The study found that consistent engagement with online training and resources was key to improvement For decades, it was a given that cognitive decline would happen with growing age. A new study published in Scientific Reports suggests that this assumpt
FACT CHECK: Can gulping sugarcane juice in one go cause diseases? (opens the original)
Read excerpt
An Instagram reel claimed drinking sugarcane juice slowly acts as medicine and gulping it causes diseases Scientific evidence does not support claims that the speed of drinking sugarcane juice or water impacts health outcomes Studies highlight sugarcane's rich polyphenol content, suggesting potential health benefits beyond its sugar content, independent of consumption speed CLAIM: An Instagram reel claims that drinking sugarcane juice slowly acts like medicine, while gulping it or water in a hur
WHO's alarming cancer warning: 1 in 5 people will get the disease (opens the original)
Read excerpt
The WHO's 2026 global cancer report projects a devastating rise in diagnoses The economic burden of cancer is projected to exceed $33.2 trillion by 2050 A stark "survival gap" exists based on wealth One in five people worldwide will develop cancer in their lifetime, and nearly everyone will feel its impact through a loved one, the WHO's 2026 global cancer report warns. With 20.6 million diagnoses in 2024 and cases projected to hit 35 million by 2050, survival still hinges starkly on wealth, rang
Government fixes prices of 39 medicines: What's cheaper,what's costlier and who benefits? (opens the original)
Read excerpt
The National Pharmaceutical Pricing Authority (NPPA) has fixed the prices of 39 medicines sold across India, revised the price of an anti-rabies injection, exempted a patented pneumococcal vaccine from price control for five years, and approved new brands of intravenous (IV) fluids under existing price orders. The decisions were issued through a series of Gazette notifications on July 8, 2026. Most of the 39 medicines are combination drugs, meaning they contain two or more active ingredients in
Paying more for IVF? Most costly add-ons lack proof of success (opens the original)
Read excerpt
IVF add-ons significantly increase the financial and emotional burden on patients A comprehensive review in The Lancet finds most popular IVF add-on treatments lack proven scientific evidence The study underscores a critical need for research integrity and patient transparency in reproductive medicine One in seven couples worldwide struggle to conceive. For many, in-vitro fertilisation (IVF) becomes the last resort. And where there is desperation, there is an industry ready to supply hope, at a
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 500K sites
For @theweek, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.